Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury - Quiz - MDSpire

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury

  • By

  • Ruxiang Sheng

  • Yanqiu Liang

  • Huihong Zhang

  • Yonghe Lai

  • Haiyun Hong

  • Dingbang Huang

  • Dezhao Liu

  • May 1, 2026

  • 0 min

Share

Original Source(s)

Bioinformatics-driven insights: rapamycin-mediated CaMK2D inhibition alleviates intestinal ischemia-reperfusion injury

  • by Ruxiang Sheng, Yanqiu Liang, Huihong Zhang, Yonghe Lai, Haiyun Hong, Dingbang Huang, Dezhao Liu

  • May 1, 2026

Related Content

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease

Modifiable Psychological Factors are Associated With Clusters of Pain, Fatigue, Fecal Incontinence, and Irritable Bowel Syndrome-Type Symptoms in Inflammatory Bowel Disease: A Latent Profile Analysis

Systematic review: The management of unhealed wounds and persistent perineal sinuses following proctectomy in inflammatory bowel disease